Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Amgen and Novartis migraine drug hits the mark again

Amgen and Novartis migraine drug hits the mark again and repurposed medicines such as the anticonvulsant topiramate or Allergan's Botox.

Race to CGRP migraine drug finish line enters the final straight

Race to CGRP migraine drug finish line enters the final straight medicines such as the anticonvulsant topiramate or Allergan's Botox.

Allergan pushes on with Botox for depression

Allergan pushes on with Botox for depression The specialty pharma group took the decision to test Botox in depression after external research groups showed evidence of efficacy in MDD in two separate early-stage trials. ... But analyst Ronny Gal of Bernstein thinks that if the gamble pays off, a

Allergan adds Zeltiq to M&A roster in $2.48n deal

Allergan adds Zeltiq to M&A roster in $2.48n deal Saunders said the deal gives its aesthetic pharmaceuticals business another pillar alongside Botox for facial wrinkles, its plastic surgery products and regenerative medicines. ... The division grew 40% to $1.62bn last year, with the sales increase

Allergan buys regenerative medicine firm LifeCell for $2.9bn

Allergan buys regenerative medicine firm LifeCell for $2.9bn Those are headed by blockbuster wrinkle treatment Botox but also include Kybella - bought along with Kythera last year for $2.1bn - for reducing double chins and dermal filler Juvederm.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics